Biopharm International, April 1st, 2005
A contract manufacturer used seven analytical methods while developing an early-phase protein therapeutic in six short months.
Contract manufacturers must plan for increased analytical resources in development and quality control.
Demand for parenteral-dose contract manufacturing services is on the rise, fueled in part by strong growth in the number of biologies in the approval process.1 With the increase in small emerging biotech companies and "virtual" pharmaceutical companies, lacking both laboratory and manufacturing facilities, contract pharmaceutical manufacturers must offer an increas...
HighBeam Research, Free Preview: 'A Case Study of Developing Analytical Methods'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.
